Cargando…
Challenging the obesity paradox: extreme obesity and COPD mortality in the SUMMIT trial
Populations with COPD demonstrate higher survival in overweight and obese compared with normal weight; the “obesity paradox”. Relationships in less-severe COPD are unclear, as is the impact of cardiovascular risk, and few studies include individuals at extremes of obesity. We examined the relations...
Autores principales: | Brigham, Emily P., Anderson, Julie A., Brook, Robert D., Calverley, Peter M.A., Celli, Bartolome R., Cowans, Nicholas J., Crim, Courtney, Diserens, James E., Martinez, Fernando J., McCormack, Meredith C., Newby, David E., Yates, Julie, Vestbo, Jorgen, Wu, Tianshi David, Wise, Robert A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311131/ https://www.ncbi.nlm.nih.gov/pubmed/34322545 http://dx.doi.org/10.1183/23120541.00902-2020 |
Ejemplares similares
-
Impact of pre-enrolment medication use on clinical outcomes in SUMMIT
por: Vestbo, Jørgen, et al.
Publicado: (2019) -
Blood pressure, heart rate, and mortality in chronic obstructive pulmonary disease: the SUMMIT trial
por: Byrd, James Brian, et al.
Publicado: (2018) -
Serum biomarkers and outcomes in patients with moderate COPD: a substudy of the randomised SUMMIT trial
por: Celli, Bartolome R, et al.
Publicado: (2019) -
International Differences in the Frequency of Chronic Obstructive Pulmonary Disease Exacerbations Reported in Three Clinical Trials
por: Calverley, Peter M. A., et al.
Publicado: (2022) -
FEV(1) is a stronger mortality predictor than FVC in patients with moderate COPD and with an increased risk for cardiovascular disease
por: Bikov, Andras, et al.
Publicado: (2020)